Deferred Acquisition Consideration (Tables)

12 Months Ended

Dec. 31, 2022

Schedule of Changes in Contingent Deferred Acquisition Consideration

The following table presents changes in contingent deferred acquisition consideration, which is measured at fair value on a recurring basis using significant unobservable inputs, and a reconciliation to the amounts reported on the Consolidated Balance Sheets as of December 31, 2022 and December 31, 2021:


	December 31, 2022		December 31, 2021
Beginning balance	$	222,369	$	17,847
Payments	(73,963)		(12,431)
Adjustments to deferred acquisition consideration (1)	(12,779)		18,721
Additions (2)	26,594		198,937
Currency translation adjustment	(759)		—
Other	(139)		(705)
Ending balance (3)	$	161,323	$	222,369

(1) Adjustment to deferred acquisition consideration contains fair value changes from the Company’s initial estimates of deferred acquisition payments. Adjustments to deferred acquisition consideration are recorded within Office and general expenses on the Consolidated Statements of Operations.

(2) In 2021, approximately $61,000 of additions represent deferred acquisition consideration acquired in connection with the acquisition of MDC. Approximately $136,000 of additions represent deferred acquisition consideration acquired in connection with the purchases of noncontrolling interests. See Note 4 of the Notes included herein for additional information related to the purchases of Concentric, Targeted Victory, and Instrument. In 2022, approximately $24,000 of additions represent deferred acquisition consideration acquired in connection with the acquisitions of BNG, Apollo, PEP Group and Epicenter. See Note 4 of the Notes included herein for additional information related to these acquisitions.

(3) As of December 31, 2022, approximately, $51,000 of the deferred acquisition consideration is expected to be settled in the Company’s Class A Common Stock.